We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Memory Pharmaceuticals and Roche Expand Development Program for MEM 3454 in Schizophrenia

News   Feb 20, 2008

 
Memory Pharmaceuticals and Roche Expand Development Program for MEM 3454 in Schizophrenia
 
 
 

RELATED ARTICLES

Popeye’s Spinach Prophecy Was Right: Low Vitamin K Linked to Poor Mobility

News

Low levels of circulating vitamin K are linked to increased risk of mobility limitation and disability in older adults, identifying a new factor to consider for maintaining mobility and independence in older age, according to a study.

READ MORE

Aging in Older Mice Delayed by Giving Enzyme From Younger Mice

News

New research has identified a novel approach to staving off the detrimental effects of aging in mice.

READ MORE

tRNA a Warning System for Oncoming Epileptic Seizures?

News

Changes in the concentration of specific transfer RNAs, a major class of noncoding RNA, are associated with epilepsy. The findings suggest that tRNA fragments could serve as an early warning system for predicting seizure risk.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE